Panel discussion on vaccine development to meet U.S. and international needs. Strategies for reducing the disincentives to HIV vaccine development: description of a successful public-private sector international collaboration.

PubWeight™: 0.95^‹?› | Rank: Top 15%

🔗 View Article (PMID 7865329)

Published in AIDS Res Hum Retroviruses on January 01, 1994

Authors

L Bronnenkant¹

Author Affiliations

1: Finishing Enterprises, N. Tonawanda, New York 14120.

Articles citing this ↘

Development of an AIDS vaccine: perspective from the South African AIDS Vaccine Initiative. BMJ (2004) 1.39